Correctiv
Support CORRECTIV

We expose injustice. We’re independent and non-profit.

Observational Study “alle mit Latanoprost sowie nicht-Latanoprost-haltige Glaukommittel (Prostaglandine)/Xalatan”

Observed Drugs

Title of the Observational Study

A6111144: LONG-TERM SURVEILLANCE STUDY OF LATANOPROST TO MONITOR HYPERPIGMENTATION CHANGE OF THE EYE IN PEDIATRIC POPULATIONS

Registered on
12/19/2014
Start date
01/01/2015
End date
01/01/2023
Executing company
Parexel International GmbH
Sponsor
Pfizer Pharma GmbH
Number of Docs1
2
Number of Patients2
14
Payment per Patient3
7200.00 €
Fee details
8 Visiten über 8 Jahre à 970€

Background

Independent journalism needs independent funding

Others can write stories. We want to reveal. We are the first investigative newsroom in Germany, which is independent, ad-free, and non-profit.

For us, the core of journalism means uncovering injustice and shortcomings in society. That’s why we investigate corruption in the health system, politicians abusing their power, and an elite that believes that rules are for the others.

To do our job, we need people, who support us. We ask you, too, to become a member and enable the work of 16 investigative journalists at CORRECTIV.

We are convinced that without independent and critical media, democracy fought for and won by our ancestors, cannot survive for long.

Independent Journalism